Navigation Links
Nyer Medical Group, Inc. Announces Pharmacy Service Agreement with East Boston Neighborhood Health Center
Date:11/12/2008

BANGOR, Maine, Nov. 12 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. (Nasdaq: NYER) announced that its pharmacy subsidiary, D.A.W., Inc. (DAW) has entered into a Pharmacy Service Agreement with East Boston Neighborhood Health Center to manage its on-site clinic pharmacy for a two-year period effective October 6, 2008. Under terms of the agreement, DAW will receive a dispensing fee for each prescription dispensed in exchange for providing comprehensive Clinical Pharmacy and Pharmacy Management Services. Management estimates that dispensing fee revenue will aggregate approximately $2 million per year. "The East Boston Neighborhood Health Center has been a community institution for over 35 years, having grown to manage and service close to 250,000 patient visits per year, one of the highest numbers of any ambulatory care center in New England. As such, we are pleased to have formed this affiliation," stated Nyer President and CEO Mark Dumouchel. "The management relationship creates further efficiencies within our operational infrastructure and will have an overall accretive effect on Nyer's earnings."

About Nyer Medical Group

Nyer Medical Group, Inc. is a holding company that through its subsidiary operates pharmacies and provides pharmacy management services to Community Health Centers in the greater Boston area.

For further information contact Mark Dumouchel (508) 429-8506, ext. 16.

Safe Harbor for Forward-Looking Statements

Certain statements contained in this press release are forward-looking in nature within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These statements are generally identified by the inclusion of phrases such as "we expect", "we anticipate", "we believe", "we estimate" and other phrases of similar meaning. Forward-looking statements include all statements that are not historical and include our statements discussing our goals, beliefs, strategies, objectives, plans, prospects and opportunities, and our statements relating to (i) the anticipated impact to be derived from the contract with the East Boston Neighborhood Health Center (ii) our ability to further operational efficiencies and fulfill the terms of the Agreement in a manner that will be accretive to earnings. These statements are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results to be materially different from those contemplated by the forward-looking statements. Such factors include: (i) the materialization of anticipated dispensing activity and projected revenue, (ii) our ability to cost-effectively retain key employees, and (iii) other factors identified in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. Except as required by law, Nyer Medical Group undertakes no obligation to release publicly the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Nyer Medical Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Anthem Blue Cross and Blue Shield Introduces International Medical Tourism Pilot Program
2. Ski Safety and Medical Experts, Victims of Snow Sport Tragedies and Consumers Shed Light on Questionable Safety Practices of California Ski Resorts
3. VNUS Medical Technologies to Present at Lazard Capital Markets 5th Annual Healthcare Conference
4. Brown Medical Industries Exhibiting at MEDICA 2008
5. Cleveland Clinic Unveils Top 10 Medical Innovations for 2009
6. CACI Awarded Three Contracts Worth $30 Million to Support Defense Medical Logistics Development
7. Symmetry Medical Reports Third Quarter 2008 Financial Results
8. Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
9. Leading Physicians To Host Medical Device Related Infection Prevention CME Webcast
10. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
11. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... As President Trump challenges the status ... his administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, ... to make it through Congress. His discussion will focus on the current state ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... the way in unveiling cutting-edge birth defects research related to Zika virus during ... the world’s premier society for this important science. , The Teratology ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology: